Myriad Genetics
MYGN
#3882
Rank
A$3.85 B
Marketcap
$42.43
Share price
-0.63%
Change (1 day)
59.13%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$0.51 B

According to Myriad Genetics's latest financial reports the company's total liabilities are A$0.51 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.53 B15.97%
2022-12-31A$0.45 B-5.26%
2021-12-31A$0.48 B
2020-06-30A$0.70 B4.61%
2019-06-30A$0.67 B138.77%
2018-06-30A$0.28 B-50.79%
2017-06-30A$0.57 B222.05%
2016-06-30A$0.17 B32.09%
2015-06-30A$0.13 B21.39%
2014-06-30A$0.11 B35.12%
2013-06-30A$82.3 M53.34%
2012-06-30A$53.67 M29.95%
2011-06-30A$41.3 M-3.06%
2010-06-30A$42.6 M6.84%
2009-06-30A$39.88 M-48.24%
2008-06-30A$77.04 M85.46%
2007-06-30A$41.54 M14.57%
2006-06-30A$36.26 M18.83%
2005-06-30A$30.51 M39.76%
2004-06-30A$21.83 M-24.59%
2003-06-30A$28.95 M-43.01%
2002-06-30A$50.8 M-20.2%
2001-06-30A$63.67 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$4.36 B 744.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.22 B 910.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$32.71 M-93.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.67 B 416.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$50.18 B 9,608.94%๐Ÿ‡บ๐Ÿ‡ธ USA